Tag: German biotech firm
WACKER to manufacture CureVac’s COVID-19 vaccine candidate in Amsterdam
German biotech firm CureVac and Wacker Chemie AG have signed a contract for the manufacturing of CureVac’s COVID-19 vaccine candidate CVnCoV.
CureVac is a biopharmaceutical...
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
